Insider · CIK 0001633639
Darren S Cline
directorofficer
Files at XENE (Xenon Pharmaceuticals Inc.), PLRX (PLIANT THERAPEUTICS, INC.), PYXS (Pyxis Oncology, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 23, 2025 | XENE Xenon Pharmaceuticals Inc. | AGrant or award Share Option (Right to Buy)derivative | +185,800 | $0.00 | $0 | 185,800 | Jun 24, 2025 |
| Jun 5, 2025 | PLRX PLIANT THERAPEUTICS, INC. | AGrant or award Common Stock (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 9, 2025 |
| Mar 31, 2025 | PYXS Pyxis Oncology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +36,979 | $0.98 | $36k | 36,979 | Apr 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.